Selvita to Present at Biotech Showcase 2019 in San Francisco

Krakow, Poland – 2 January 2019 – Selvita (WSE:SLV), a clinical stage drug discovery and development company engaged in the research and development of novel cancer therapies, today announced that Chief Executive Officer Pawel Przewiezlikowski will present a corporate overview at the Biotech Showcase 2019 conference taking place Jan. 7-9…

More